Ryan D. Maynard
2017
In 2017, Ryan D. Maynard earned a total compensation of $1.1M as Former Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $227,293 |
|---|---|
| Option Awards | $393,545 |
| Salary | $454,585 |
| Other | $1,170 |
| Total | $1,076,593 |
Maynard received $454.6K in salary, accounting for 42% of the total pay in 2017.
Maynard also received $227.3K in non-equity incentive plan, $393.5K in option awards and $1.2K in other compensation.
Rankings
In 2017, Ryan D. Maynard's compensation ranked 8,635th out of 14,666 executives tracked by ExecPay. In other words, Maynard earned more than 41.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,635 out of 14,666 | 41st |
Division Manufacturing | 3,281 out of 5,768 | 43rd |
Major group Chemicals And Allied Products | 1,104 out of 2,074 | 47th |
Industry group Drugs | 876 out of 1,730 | 49th |
Industry Pharmaceutical Preparations | 684 out of 1,329 | 49th |
Source: SEC filing on April 4, 2018.
Maynard's colleagues
We found five more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2017.
2017
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2017
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2017
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
2017
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2017
Esteban Masuda
Rigel Pharmaceuticals